Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel stigmasterol based UDCA preparation method ensures high purity and supply chain stability for pharmaceutical intermediates manufacturing processes.
Discover the patented ionic liquid process for epsilon-caprolactam production offering high purity, reduced waste, and scalable manufacturing for global polymer supply chains.
Advanced semi-synthetic route for high-purity Astilbin from Myricitrin. Enhancing supply chain stability and cost efficiency for pharmaceutical and functional food applications.
Patent CN100349902C reveals a low-toxicity route for isocyanate silane. Achieve high purity and cost reduction in polyurethane sealant manufacturing with scalable technology.
Novel catalytic method for Yanhuning bulk pharmaceutical ensures high yield and purity. Optimize supply chain with scalable API intermediate manufacturing processes.
Patent CN105601538A details high-yield cyhalofop-butyl production. Enhances supply chain reliability and reduces manufacturing costs for global herbicide markets.
Patent CN107108639A reveals a safer Forodesine route eliminating hydrogenation. Discover cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel photochemical route for benzyl phosphine oxides. High yield up to 81%. Metal-free process ensures cost reduction in API manufacturing and supply chain stability.
Novel graphene-supported ruthenium catalyst method ensures high purity and selectivity for polymer and specialty chemical manufacturing supply chains.
Novel synthesis route for high-purity naphthamide intermediates offering cost reduction and supply chain reliability for pharmaceutical applications.
Patent CN108822139A reveals a novel copper complex catalyst enabling high conversion Henry reactions. Discover supply chain advantages and scalable synthesis routes for fine chemical intermediates.
Advanced synthesis of 5-(4-methyl-1H-imidazol-1-yl)-3-trifluoromethyl-aniline via patent CN102174020B. Delivers superior purity, safety, and cost efficiency for kinase inhibitor supply chains.
Novel Mycobacterium neoaurum enables high-yield 9-OH AD production with simplified purification for reliable pharmaceutical intermediate supply chains and cost efficiency.
Patent CN103215238A reveals a novel marine esterase PE8 for producing (R)-3-(4-fluorophenyl) monomethyl glutarate, offering a cost-effective enzymatic route for antidepressant intermediates.
Patent CN101392225A reveals a recombinant yeast route for high-purity (S)-CHBE, offering significant cost reduction in API manufacturing and robust supply chain scalability.
Advanced solvent-free Fries rearrangement process for o-hydroxyacetophenone and p-hydroxyacetophenone. Delivers high purity, reduced costs, and scalable supply chain solutions.
Patent CN114703169A reveals a novel L-threonine aldolase mutant for Droxidopa. Achieves 92.89% selectivity. Ideal for pharma intermediates supply.
Novel chiral phase transfer catalyst enables high-purity S-2-6-dimethyl tyrosine production with significant cost reduction and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN113308443B reveals a mutant monooxygenase boosting azaphilone yield to 92.8%. Discover cost-effective, scalable biocatalytic manufacturing solutions.
Discover a novel Brønsted acid-catalyzed synthesis for benzopyran derivatives. This patent-backed route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.